Enter your keywords
HOME
About Us
NEWSLETTER
To search AlzRisk, use the "Keyword" search on the
AlzRisk search page
.
NEWS
All News
Conference Coverage
Series
WEBINARS
All Webinars
Databases
AlzBiomarker
AlzPedia
AlzRisk
Antibodies
Genetics
AlzGene
HEX
Mutations
Protocols
Research Models
Therapeutics
PAPERS
All Papers
Papers of the Week
Milestone
Alzforum Recommends
PROFESSIONAL RESOURCES
Conference Calendar
Grants
Jobs
Member Directory
ABOUT AD
AD Overview
Early-Onset Familial
The HBO Alzheimer's Project
Supported Browsers
MY ALZFORUM
My AlzForum Home
View Library
View Notifications
Set Notifications
Edit Profile
AlzRisk Paper Detail
Risk Factors
Alcohol
B Vitamins
Blood Pressure
Cognitive Activity
Diabetes Mellitus
Dietary Pattern
Head injury
Homocysteine
Hormone Therapy
Inflammatory Biomarkers
Non-Steroidal Anti-Inflammatory Drugs
Nutritional Antioxidants
Obesity
Physical Activity
Statin use
Reference:
Bermejo-Pareja, 2010
Cohort:
Neurological Disorders in Central Spain
Risk Factor:
Blood Pressure
Average Follow-up Time Detail
The baseline examination occurred between 1994 and 1995, while the follow-up evaluation occurred between 1997 and 1998.
"3,658 (73.6%) participants completed the follow-up evaluation...in the final cohort, we also included 231 (37.1%) of the 620 deceased participants who had adequate medical records...the final cohort of 3,824 participants consisted of 3,208 participants who screened negative [at follow-up] for dementia, 385 who screened positive [at follow-up] and who were either examined or had adequate medical records, and 231 deceased participants [at follow-up]with adequate medical records."
Exposure Detail
"At baseline, all participants were asked whether or not they had a history of hypertension (diagnosed by their doctor) at any time during their life. If their response was affirmative, they were asked whether or not they were under treatment, the specific type of treatment (drugs, diet, other general measures), and the duration of hypertension and therapy...In this study, we considered a person as hypertensive if he/she answered positively to the hypertension question or if he/she had taken any pharmacological drug for hypertension."
Ethnicity Detail
"The NEDICES study went into a well-defined area of central Spain and sampled three geographic areas...which represent the broad spectrum of Spanish societies..Las Margaritas, a working class neighborhood in Getafe (Greater Madrid); Lista, a professional-class neighborhood in Salamanca district (Central Madrid); and Arevalo, the agricultural region of Arevalo county (125 km northwest of Madrid)."
Age Detail
Entry criteria required all participants to be age 65 or older at study entry.
Screening and Diagnosis Detail
Screening Method:
MMSE
Mini-Mental State Examination (Folstein 1975)
Other
Pfeffer FAQ
Pfeffer Functional Activities Questionnaire
AD Diagnosis:
NINCDS ADRDA
National Institute of Neurological and Communicative Diseases and Stroke/Alzheimer's Disease and Related Disorders Association Criteria (McKhann 1984)
Total dementia definition:
DSM-IV
"The diagnosis of dementia at baseline or during follow-up was made by the consensus of two neurologists, who were blinded to hypertension status, and was based on the neurological assessment and examination. The medical records of all participants who received a diagnosis of dementia were reviewed by a senior neurologist (F.B.P.) with the aid of a psychologist. If there were doubts about any aspect of the dementia diagnosis, additional information (mainly from family doctors) was elicited."
Covariates & Analysis Detail
Analysis Type:
Cox proportional hazards regression
"Person-years for participants who did not develop dementia were calculated as the time between the baseline screening and the screening for the follow-up survey or death. Conversely, person-years for participants who developed dementia were calculated as the time between the baseline screening and the reported onset of cognitive complaints. If the onset of cognitive complaints was unknown, person-years were calculated as the midpoint between the baseline screening and the follow-up screening or death."
The reported associations adjust for several factors that may mediate the relationship between blood pressure and Alzheimer disease. Unadjusted and partially adjusted models yield effect sizes of similar direction and magnitude.
AD Covariates:
A
age
E
education
G
gender
CHD
coronary heart disease
DEP
depression
DM
diabetes mellitus
HC
high cholesterol
RES
residential township
SD
sleep duration
SH
stroke history
TD Covariates:
A
age
E
education
G
gender
CHD
coronary heart disease
DEP
depression
DM
diabetes mellitus
HC
high cholesterol
RES
residential township
SD
sleep duration
SH
stroke history